{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T07:28:31Z","timestamp":1751873311767},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T00:00:00Z","timestamp":1693353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T00:00:00Z","timestamp":1693353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Medullary thyroid carcinoma (MTC) is a neuroendocrine tumor that originates from parafollicular C-cells. Calcitonin (Ctn) and carcinoembryonic antigen (CEA) are useful biomarkers for monitoring MTC cases.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>Here, we describe a 48-year-old woman, who presented in 2014 with bilateral thyroid nodules. Report of fine needle aspiration was suspicious for MTC; initial laboratory evaluation showed serum Ctn level of 1567 pg\/mL. After excluding type 2 multiple endocrine neoplasia syndrome clinically, total thyroidectomy and neck lymph node dissection were performed. The final histopathological diagnosis was right lobe MTC with neither vascular invasion nor lymph node involvement. On regular follow-up visits, Ctn and CEA levels have been undetectable, and repeated cervical ultrasonographic exams were unremarkable from 2014 to 2021. As liver enzymes became elevated in 2016, the patient was further evaluated by a gastroenterologist. Abdominopelvic ultrasonography revealed a coarse echo pattern of the liver parenchyma with normal bile ducts. A liver fibroscan showed a low fibrosis score (7kPa). The patient was recommended to use ursodeoxycholic acid. According to the progressive rise of liver enzymes with a cholestatic pattern in October 2020, a liver biopsy was performed that showed tiny nests of neuroendocrine-like cells with a background of primary biliary cholangitis (PBC). Immunohistochemical stainings were positive for chromogranin A (CgA), and synaptophysin and negative for Ctn, CEA, and thyroglobulin. Further imaging investigations did not reveal any site of a neuroendocrine tumor in the body. Considering normal physical exam, imaging findings, as well as normal serum levels of Ctn, CEA, CgA, and procalcitonin, the patient was managed as a PBC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In follow-up of a patient with MTC, we reported progressively increased liver enzymes with a cholestatic pattern. Liver biopsy revealed nests of neuroendocrine-like cells with a background of PBC, the findings that might suggest acquiring neuroendocrine phenotype by proliferating cholangiocytes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12902-023-01439-7","type":"journal-article","created":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T07:02:17Z","timestamp":1693378937000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic dilemma in a patient with history of medullary thyroid carcinoma and abnormal serum liver enzymes; a case report with six years follow up"],"prefix":"10.1186","volume":"23","author":[{"given":"Fatemeh","family":"Rahmani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Tohidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farid","family":"Azmoudeh-Ardalan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farzad","family":"Hadaegh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,30]]},"reference":[{"issue":"3","key":"1439_CR1","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.ecl.2007.04.001","volume":"36","author":"DW Ball","year":"2007","unstructured":"Ball DW. Medullary thyroid cancer: monitoring and therapy. Endocrinol Metab Clin North Am. 2007;36(3):823\u201337.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"6","key":"1439_CR2","doi-asserted-by":"publisher","first-page":"e439","DOI":"10.4158\/ACCR-2017-0260","volume":"4","author":"T Tofail","year":"2018","unstructured":"Tofail T, Fariduddin M, Haq T, Selim S, Jahan S, Khan MA, Mustari M, Banu H, Alam R, Joarder A. Metastatic medullary thyroid carcinoma with normal serum calcitonin levels. AACE Clin Case Rep. 2018;4(6):e439\u201342.","journal-title":"AACE Clin Case Rep"},{"issue":"2","key":"1439_CR3","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1210\/jc.2006-1590","volume":"92","author":"G Costante","year":"2007","unstructured":"Costante G, Meringolo D, Durante C, Bianchi D, Nocera M, Tumino S, Crocetti U, Attard M, Maranghi M, Torlontano M. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. J Clin Endocrinol Metab. 2007;92(2):450\u20135.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1439_CR4","first-page":"326","volume":"67","author":"A Al-Salameh","year":"2016","unstructured":"Al-Salameh A, Baudry C, Gautier JF, Toubert M-E, Bihan H, Cohen R. Late liver metastasis of medullary thyroid cancer with low calcitonin levels\u2014successfully cured by radiofrequency. Endokrynol Pol. 2016;67(3):326\u20139.","journal-title":"Endokrynol Pol"},{"issue":"6","key":"1439_CR5","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1089\/thy.2014.0335","volume":"25","author":"SA Wells Jr","year":"2015","unstructured":"Wells SA Jr, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, Lee N, Machens A, Moley JF, Pacini F. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma: the American Thyroid Association Guidelines Task Force on medullary thyroid carcinoma. Thyroid. 2015;25(6):567\u2013610.","journal-title":"Thyroid"},{"issue":"1","key":"1439_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12902-019-0435-7","volume":"19","author":"C Gambardella","year":"2019","unstructured":"Gambardella C, Offi C, Patrone R, Clarizia G, Mauriello C, Tartaglia E, Di Capua F, Di Martino S, Romano RM, Fiore L. Calcitonin negative Medullary Thyroid Carcinoma: a challenging diagnosis or a medical dilemma? BMC Endocr Disord. 2019;19(1):1\u201312.","journal-title":"BMC Endocr Disord"},{"key":"1439_CR7","doi-asserted-by":"crossref","unstructured":"Raue F, Frank-Raue K. Long-term follow-up in medullary thyroid carcinoma. Medullary Thyroid Carcinoma: Biology\u2013Management\u2013Treatment. 2015;204:207-25.","DOI":"10.1007\/978-3-319-22542-5_10"},{"issue":"2","key":"1439_CR8","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1159\/000494675","volume":"8","author":"S Censi","year":"2019","unstructured":"Censi S, Cavedon E, Watutantrige-Fernando S, Barollo S, Bertazza L, Manso J, Iacobone M, Nacamulli D, Galuppini F, Pennelli G. Unique Case of a Large Indolent Medullary Thyroid Carcinoma: Time to Reconsider the Medullary Thyroid Adenoma Entity? European Thyroid Journal. 2019;8(2):108\u201312.","journal-title":"European Thyroid Journal"},{"issue":"18","key":"1439_CR9","doi-asserted-by":"publisher","first-page":"4670","DOI":"10.3390\/cancers13184670","volume":"13","author":"H Park","year":"2021","unstructured":"Park H, Yang H, Heo J, Kim TH, Kim SW, Chung JH. Long-Term Outcomes and Causes of Death among Medullary Thyroid Carcinoma Patients with Distant Metastases. Cancers. 2021;13(18):4670.","journal-title":"Cancers"},{"key":"1439_CR10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ijscr.2019.01.025","volume":"55","author":"N Chen","year":"2019","unstructured":"Chen N, Slater K. Primary hepatic neuroendocrine tumours\u2014Case series of a rare malignancy. Int J Surg Case Rep. 2019;55:145\u20138.","journal-title":"Int J Surg Case Rep"},{"issue":"4","key":"1439_CR11","doi-asserted-by":"publisher","first-page":"956","DOI":"10.3892\/ol.2014.1844","volume":"7","author":"Z Chen","year":"2014","unstructured":"Chen Z, Xiao HE, Ramchandra P, Huang HJ. Imaging and pathological features of primary hepatic neuroendocrine carcinoma: An analysis of nine cases and review of the literature. Oncol Lett. 2014;7(4):956\u201362.","journal-title":"Oncol Lett"},{"issue":"1","key":"1439_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40644-015-0046-0","volume":"15","author":"L-X Wang","year":"2015","unstructured":"Wang L-X, Liu K, Lin G-W, Jiang T. Primary hepatic neuroendocrine tumors: comparing CT and MRI features with pathology. Cancer Imaging. 2015;15(1):1\u20137.","journal-title":"Cancer Imaging"},{"issue":"1","key":"1439_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1757-1626-2-90","volume":"2","author":"C-W Lin","year":"2009","unstructured":"Lin C-W, Lai C-H, Hsu C-C, Hsu C-T, Hsieh P-M, Hung K-C, Chen Y-S. Primary hepatic carcinoid tumor: a case report and review of the literature. Cases J. 2009;2(1):1\u20136.","journal-title":"Cases J"},{"issue":"5","key":"1439_CR14","doi-asserted-by":"publisher","first-page":"546","DOI":"10.4318\/tjg.2012.0370","volume":"23","author":"C Jia","year":"2012","unstructured":"Jia C, Zhang Y, Xu J, Sun K. Experience in primary hepatic neuroendocrine tumor. Turk J Gastroenterol. 2012;23(5):546\u201351.","journal-title":"Turk J Gastroenterol"},{"issue":"5","key":"1439_CR15","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1007\/s10517-016-3254-0","volume":"160","author":"N Lyubimova","year":"2016","unstructured":"Lyubimova N, Churikova T, Kushlinskii N. Chromogranin as a biochemical marker of neuroendocrine tumors. Bull Exp Biol Med. 2016;160(5):702\u20134.","journal-title":"Bull Exp Biol Med"},{"issue":"8","key":"1439_CR16","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1111\/j.1440-1746.2012.07117.x","volume":"27","author":"CH Park","year":"2012","unstructured":"Park CH, Chung JW, Jang SJ, Chung MJ, Bang S, Park SW, Song SY, Chung JB, Park JY. Clinical features and outcomes of primary hepatic neuroendocrine carcinomas. J Gastroenterol Hepatol. 2012;27(8):1306\u201311.","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"1439_CR17","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1177\/147323000803600428","volume":"36","author":"A Zhang","year":"2008","unstructured":"Zhang A, Xiang J, Zhang M, Zheng S. Primary hepatic carcinoid tumours: clinical features with an emphasis on carcinoid syndrome and recurrence. J Int Med Res. 2008;36(4):848\u201359.","journal-title":"J Int Med Res"},{"issue":"1","key":"1439_CR18","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1053\/j.gastro.2006.07.023","volume":"132","author":"D Alvaro","year":"2007","unstructured":"Alvaro D, Mancino MG, Glaser S, Gaudio E, Marzioni M, Francis H, Alpini G. Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver. Gastroenterology. 2007;132(1):415\u201331.","journal-title":"Gastroenterology"},{"key":"1439_CR19","doi-asserted-by":"crossref","unstructured":"Scrushy M, O'Brien A, Glaser S. Recent advances in understanding bile duct remodeling and fibrosis. F1000Res. 2018;7(1165).","DOI":"10.12688\/f1000research.14578.1"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-023-01439-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-023-01439-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-023-01439-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T03:07:10Z","timestamp":1700449630000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-023-01439-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,30]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1439"],"URL":"https:\/\/doi.org\/10.1186\/s12902-023-01439-7","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,30]]},"assertion":[{"value":"27 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the patient for representing this case report. A copy of the written consent is available for review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication was obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"186"}}